Through innovative R&D in nanomedicine, we seek to restore freedom, happiness, and the ability to live fully to those affected by cancer.
We took an effective chemotherapy drug and made it much safer, with no side effects.
Onselex has built a broad intellectual property portfolio covering its nanoparticle platform and therapeutic applications.
Onselex is expanding its pipeline by developing innovative and effective new drugs.
Pancreatic·Liver Cancer Nanomedicine
Ovarian Cancer Nanomedicine
Gastric·Colorectal Cancer Oral Nanomedicine
Company History
Leadership
May pursue strategic partnerships with global pharmaceutical companies, including co-development, licensing, and commercialization.
Freedom, happiness, and a return to normal life.